Emyria Limited

ASX:EMD Stock Report

Market Cap: AU$37.1m

Emyria Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure2.5yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

Analysis Article • Jul 04

Here's Why We're Not Too Worried About Emyria's (ASX:EMD) Cash Burn Situation

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Feb 02

Will Emyria (ASX:EMD) Spend Its Cash Wisely?

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Analysis Article • May 20

We're Hopeful That Emyria (ASX:EMD) Will Use Its Cash Wisely

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Analysis Article • Oct 20

Here's Why We're Not Too Worried About Emyria's (ASX:EMD) Cash Burn Situation

Just because a business does not make any money, does not mean that the stock will go down. For example, Emyria...
Analysis Article • Jun 11

We Think Emyria (ASX:EMD) Needs To Drive Business Growth Carefully

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Emyria ( ASX:EMD...
Analysis Article • Feb 25

Will Emyria (ASX:EMD) Spend Its Cash Wisely?

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Analysis Article • Nov 17

Need To Know: Emyria Limited (ASX:EMD) Insiders Have Been Buying Shares

We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...

CEO

Emyria has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Gregory Hutchinson
Executive Chairman2.8yrsAU$330.91k5.29%
A$ 2.0m
Michael Winlo
Chief Scientific Officer & Executive Director1.6yrsAU$401.91k0.16%
A$ 60.9k
Joseph Ohayon
Chief Financial Officerno datano datano data
Alistair Vickery
Executive Medical Director & Director7.4yrsAU$485.37kno data
Tracie Ernenwein
Head of Research & Drug Developmentno datano datano data
Mary-Ann Rennie
Head of Corporate Operationsno datano datano data
Susan Park
Company Secretary3.4yrsno datano data
2.5yrs
Average Tenure

Experienced Management: EMD's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gregory Hutchinson
Executive Chairman2.8yrsAU$330.91k5.29%
A$ 2.0m
Michael Winlo
Chief Scientific Officer & Executive Director6.8yrsAU$401.91k0.16%
A$ 60.9k
Alistair Vickery
Executive Medical Director & Director6.8yrsAU$485.37kno data
Henry Bosch
Member of Medical Advisory Boardno datano datano data
John Tooke
Member of Medical Advisory Board & Independent Non-Executive Director6.5yrsAU$50.00kno data
Mohit Kaushal
Non-Executive Director3yrsAU$94.05k0.25%
A$ 92.0k
Karen Smith
Non-Executive Director & Chairman of Strategic Advisory Board5.5yrsAU$50.00k0.079%
A$ 29.1k
David Putrino
Member of Medical Advisory Boardno datano datano data
Nik Zeps
Member of Medical Advisory Boardno datano datano data
Philip Finch
Member of Medical Advisory Boardno datano datano data
Jennifer Morgan
Member of Medical Advisory Boardno datano datano data
Richard Magtengaard
Member of Medical Advisory Board5.5yrsno datano data
5.5yrs
Average Tenure
58yo
Average Age

Experienced Board: EMD's board of directors are considered experienced (5.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/13 20:28
End of Day Share Price 2026/08/13 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Emyria Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.